Royalty Rates in Pharmaceutical and Biotechnology Deals 2010 to 2025

Executive Summary

 

Chapter 1 – Introduction

1.1. What are royalties?

1.2. History of royalty rates

1.3. Royalties in pharmaceuticals and biotechnology

1.4. Royalties versus revenue share

1.5. Overview of the report

 

Chapter 2 – An overview of pharmaceutical and biotechnology royalty rates

2.1. Trends in royalty rates 2010 - 2025

2.2. How do revenue shares figure?

2.3. A review of recent literature

2.4. Royalty rates in the future

 

Chapter 3 – The royalty clause in pharmaceutical and biotechnology deals

3.1. Partnering agreement structure

3.2. Structure of a typical royalty clause

3.3. Example royalty clauses

3.3.1. Case study 1

3.3.2. Case study 2

3.3.3. Case study 3

3.3.4. Case study 4

 

Chapter 4 – Companies actively disclosing royalty rates

4.1. Most active companies in disclosing royalty rates

 

Chapter 5 – Royalty rate contract directory

Explore royalty rates within the deal contract document to gain greater insight

 

Deal Directory

Deal Directory – Royalty rates in deals – by company A-Z

Deal Directory – Royalty rates in deals - by therapy area

Deal Directory – Royalty rates in deals - by stage of development at signing

Deal Directory – Royalty rates in deals - by technology type

 

Royalty rate references

Example royalty rate deal contract document

About Biopharma Research Ltd

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

Figure 1: Trends in pharma and biotech royalty rates, 2010 - 2025

Figure 2: Components of the partnering deal structure

Figure 3: Components of the partnering royalty clause

Figure 4: Most active companies disclosing royalty rate 2010 - 2025

Figure 5: Licensing agreement for rhAAT – rEVO Biologics, LFB Biotechnologies

Pricing options

• $4,995: single-user (encrypted file - one user/device)
• $6,995: multi-user (encrypted file - up to 5 users/devices)
• $7,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Biopharma Research Ltd based in York, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

2seventy bio, 3a-diagnostics, 3B Pharmaceuticals, 3D Medicines, 3SBio, 4D Molecular Therapeutics, 4SC, 9 Meters Biopharma, 23andMe, Aadi Bioscience, Abbisko Therapeutics, Abbott Laboratories, Abbvie, AbCellera Biologics, Abeona Therapeutics, Abex Pharmaceutica, ABL Bio, Ablynx, Abraxis BioScience, ABVC BioPharma, ABX, ACADIA Pharmaceuticals, Acceleron Pharma, Accent Therapeutics, Accord Healthcare, Acelrx Pharmaceuticals, Acer Therapeutics, Acerus, AC Immune, Aclaris Therapeutics, Acorda Therapeutics, Acrotech Biopharma, Actavis (acquired by Watson), Actinium Pharmaceuticals, Active Biomaterials, Acuitas Therapeutics, Acumen Pharmaceuticals, Acura Pharmaceuticals, Adamis Pharmaceuticals, Adaptimmune, AdaptVac, Adcendo, ADC Therapeutics, Adeona Pharmaceuticals, Adial Pharmaceuticals, Adimab, Aditx Therapeutics, Adlai Nortye, Adocia, Adovate, Aduro BioTech, Advaccine Biotechnology, Advanced Dosage Forms, Advanz Pharma, Advaxis, Advirna, Aegerion Pharmaceutical, Aeglea BioTherapeutics, Aelis Pharma, Aerami Therapeutics, Aerie Pharmaceuticals, Aeromics, Aerpio Pharmaceuticals, AEterna Zentaris, Aevi Genomic Medicine, Aexon Labs, Affibody, Affimed Therapeutics, AFFiRiS, Afritex Medical Products, AFT Pharmaceuticals, Agenus Bio, Agios Pharmaceuticals, AgNovos Healthcare, Aguettant, AiBtl BioPharma, Aimmune Therapeutics, Aitia, AIT Therapeutics, Akamis Bio, Akcea Therapeutics, Akebia Therapeutics, Akeso Biopharma, Alaunos Therapeutics, Albert Einstein College of Medicine, Albireo, Alchemia, Alder Biopharmaceuticals, Alector, Alexion Pharmaceuticals, Alexza Pharmaceuticals, Alfasigma, Alfa Wassermann, ALK-Abello, Alkem Laboratories, Allecra Therapeutics, Allergan, Allergan (name changed from Actavis), Allist Pharma, Allogene Therapeutics, Almirall, Alnylam Pharmaceuticals, Alora Pharmaceuticals, Alpha Biopharma, Alphamab Biopharmaceuticals, Alphamab Oncology, Alpine Immune Sciences, Altamira Pharma, Alteogen, Alternavida, Altesa Biosciences, Altman Enterprises, AltrazealTrading, Altum Pharmaceuticals, Alumis, Aluztra Bio, Alvogen, Amag Pharmaceuticals, Amarantus BioSciences, Amarin, Ambrx, American Type Culture Collection (ATCC), Amgen, Amherst Pharmaceuticals, Amicus Therapeutics, AMMTeK, Amneal Pharmaceuticals, Amorfix Life Sciences, Amphista Therapeutics, Ampio Pharmaceuticals, Amplyx Pharmaceuticals, Amryt Pharma, Amylin Pharmaceuticals, Amylyx Pharmaceuticals, Amyris, AnaBios, AnaptysBio, AnGes MG, Angion Biomedica, AnHeart Therapeutics, Anima Biotech, Anivive Lifesciences, AnnaMed, AnnJi Pharmaceutical, Antares Pharma, Antengene, Anteris Bio, Antibe Therapeutics, Antigen Express, Antion Biosciences, Apellis Pharmaceuticals, Apic Bio, ApolloBio, Apollo Therapeutics, Applied Therapeutics, Apricus Biosciences, AprilBio, Aptamer Therapeutics, Aptose Biosciences, Aquestive Therapeutics, Aradigm, Aratana Therapeutics, Aravive Biologics, Arbormentis, Arbutus, ARCA Biopharma, Arcellx, Arch Pharmalabs, Arctic Vision, Arcturus Therapeutics, Arcus Biosciences, Arcutis Biotherapeutics, Ardelyx, Arena Pharmaceuticals, argenx, Ariad Pharmaceuticals, Aridis Pharmaceuticals, Arlington Scientific, ArQule, Arrakis Therapeutics, Array Biopharma, Arrowhead Pharmaceuticals, ARScience Biotherapeutics, ARS Pharmaceuticals, Artios Pharma, Artiva Biotherapeutics, Arvinas, Asahi Kasei, Ascendis Pharma, Asceneuron, Ascentage Pharma, Ascletis, Ashvattha Therapeutics, ASKA Pharmaceuticals, Aslan Pharma, Aspire Health Science, Aspire Pharma, Assembly Biosciences, Assistance Publique-Hôpitaux de Paris, Astellas Pharma, Astellas Pharma Europe, Asterias Biotherapeutics, AstraZeneca, Astria Therapeutics, Atara Biotherapeutics, Athenex, Athersys, Atlantic Healthcare, Atossa Therapeutics, Atreca, Audentes Therapeutics, Audeo Oncology, Augmenta, AUM Biosciences, Auransa, Aurealis Therapeutics, Aurigene Discovery Technologies, Aurinia Pharmaceuticals, Authentic Brands Group, Autolus, Avacta, Avalo Therapeutics, Avata Biosciences, Avecho Biotechnology, Avenue Therapeutics, AVEO Oncology, Avero Diagnostics, Avid Bioservices, Avidity Biosciences, Avita Therapeutics, Avivagen, Axovant Gene Therapies, Axsome Therapeutics, Aytu BioPharma, Azaya Therapeutics, Azure Biotech, Baker Brothers Investments, BAKX Therapeutics, Baliopharm, BASF, Basilea Pharmaceutica, Bausch Health Companies, Bavarian Nordic, Baxalta, Baxter International, Bayer, Bayer Healthcare, Bayer Innovation, Baylor Research Institute, Beam Therapeutics, BeiGene, Beijing Defengrei Biotechnology, Beijing InnoCare Pharma, Beijing Mabworks Biotech, Beijing Podconley Pharmaceutical Technology and Development, Belgian Volition, Bellerophon Therapeutics, Bellicum Pharmaceuticals, Benitec Biopharma, Benuvia Therapeutics, Besins Healthcare, Beta Bionics, Beth Israel Deaconess Medical Center, Betta Pharmaceuticals, BetterLife Pharma, Bharat Biotech, BICO, Bicycle Therapeutics, BIND Biosciences, Bio-Rad Laboratories, Bio-Thera Solutions, BioArctic AB, biOasis Technologies, BioAtla, Biocon, BioCorRx, BioCryst Pharmaceuticals, Biocytogen, BioDelivery Sciences, Biodexa Pharmaceuticals, Bioeq IP, Biogen, BioGene Technology, BioGenetics, Biohaven Pharmaceuticals, BioHEP Technologies, BioInvent, BiolineRX, Biolojic Design, BioMarin Pharmaceutical, Biomerica, Biond Biologics, BioNova Pharmaceuticals, BioNovion, BioNTech, BioNxt Solutions, Biopas Laboratories, Biopharmex, BiopharmX, BioPhausia, Biophytis, BioPorto, Bioprocess Capital Ventures, Bioprojet, BioProspect, Biora Therapeutics, BioSense Global, Biosion, Biosplice, Biostem US, Biotech Investment, Biotechnology Value Fund, BioTheryX, BioTime Acquisition, Bioton, Biovail, Bioverativ, BioZone Laboratories, BioZone Pharmaceuticals, Bixink Therapeutics, Blackstone, Blanver, Bluebird Bio, Blueprint Medicines, BlueRock Therapeutics, BMV Medica, BNC Korea, Boehringer Ingelheim, Bone Therapeutics, Boryung Pharmaceutical, Botanix Pharmaceuticals, Braeburn Pharmaceuticals, BrainStorm Cell Therapeutics, Breathtec BioMedical, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, BridGene Biosciences, Brigham and Women's Hospital, Brii Biosciences, Bristol-Myers Squibb, C4 Therapeutics, Cabaletta Bio, Caleco Pharma, Calico, Calidi Biotherapeutics, California Institute for Biomedical Research, Calithera Biosciences, Calliditas Therapeutics, CAMP4 Therapeutics, Camurus, Can-Fite BioPharma, CanAm Bioresearch, CANbridge Pharmaceuticals, Cancer Prevention Pharmaceuticals, Cannassure Therapeutics, CanniMed Therapeutics, Cann Pharmaceutical Australia, Canntab Therapeutics, Cannus Partners, CanProbe, Cantabria Pharma, Cantargia, Cantex Pharmaceuticals, Capricor Therapeutics, Capsida Biotherapeutics, Cara Therapeutics, Cardiff University, Cardigant Medical, Cardium Therapeutics, CareFusion, Caribou Biosciences, Carna BioSciences, Carpegen, Cary Pharmaceuticals, CASI Pharmaceuticals, Cassiopea, Castle Biosciences, Castle Creek Biosciences, Catalent, Catalyst Pharmaceuticals, Catholic University Leuven, CB2 Therapeutics, Cedars-Sinai Medical Center, Celdara Medical, Celgene, CellAct, Cell Cure Neurosciences, Cellectis, Cellenkos, Cellerant Therapeutics, Cellular Biomedicine, Cellvera, Cel Sci, Celyad, Cend Therapeutics, Centessa Pharmaceuticals, Centrexion, Cereal Ingredients, Cerebain Biotech, Cerus, CGA 369, cGreen, Checkpoint Therapeutics, Chelexa Biosciences, Chengdu Kanghua Biological Products, Chi-Med, Chiesi Farmaceutici, Chimerix, China Oncology Focus, Chinese University of Hong Kong, Chinook Therapeutics, Chong Kun Dang, Chongqing Jingdong Pharmaceutical, Chugai Pharmaceutical, Cidara Therapeutics, Cilag AG, Cimtech, Cipher Pharmaceuticals, Cipla, Circassia, Citius Pharmaceuticals, City of Hope, City Therapeutics, Clal Biotech, Clalit Health Services, Clearmind Medicine, Clearside Biomedical, Cleave Therapeutics, Clementia Pharmaceuticals, Clemson University, Cleveland BioLabs, Click Therapeutics, Climb Bio, Clinigen, Clovis Oncology, CMG Pharmaceutical, CMIC, CMS Medical, CNS Pharmaceuticals, Coave Therapeutics, Cocrystal Pharma, Codex DNA, Codexis, Codiak BioSciences, Coeptis Pharmaceuticals, CohBar, Cohen-McNiece Foundation, Coherus Biosciences, Colby Pharmaceuticals, Collegium Pharmaceuticals, Columbia Care, Columbia Laboratories, Columbia University, Common Sense, Compugen, Conatus Pharmaceuticals, Concile, ConforMIS, Consilient Health, Context Therapeutics, Contineum Therapeutics, ContraFect, Copernicus Therapeutics, Corbus Pharmaceuticals, CorMatrix Cardiovascular, Coronado Biosciences, Cortice Biosciences, CORXEL Pharmaceuticals, Cosmofix, Cosmo Pharmaceuticals, COUR Pharmaceutical, Coya Therapeutics, Crescita Therapeutics, Crestovo, CRISPR Therapeutics, Crossject, Crosswalk Therapeutics, CRT Pioneer Fund, Crucell, CrystalGenomics, CSL, CSL Behring, CSPC Pharmaceutical Group, CS Pharmaceuticals, CStone Pharmaceuticals, CTI BioPharma, CTT Pharmaceutical, Cue Biopharma, Cullinan Oncology, Cullinan Therapeutics, Cumberland Pharmaceuticals, Cumulus Oncology, Curadev Pharma, Curasight, Cures Within Reach, CureTech, Curetis, CureVac, Curis, Curium, Curon Biopharmaceutical, Currax Pharmaceuticals, CURx Pharmaceuticals, Cutanea Life Sciences, Cybin, Cyclerion Therapeutics, CymaBay Therapeutics, Cypress Bioscience, Cyprium Therapeutics, Cytodyn, Cytokinetics, CytoLynx Therapeutics, CytomX Therapeutics, Cytori Therapeutics, Cytovant Sciences, CYTOVIA Therapeutics, CytRx, D&D Pharmatech, D. E. Shaw Research, Daewoong Pharmaceutical, Daiichi Sankyo, Dana-Farber Cancer Institute, Dance Biopharm, Dare Bioscience, DAS Therapeutics, Day One Biopharmaceuticals, DCx Biotherapeutics, Debiopharm, Decibel Therapeutics, Deciphera Pharmaceuticals, Defiante Farmaceutica, Deimos Biosciences, DelSiTech, Denali Therapeutics, Department of Health and Human Services, DepoMed, Derma Sciences, Dermavant Sciences, Dermelix Biotherapeutics, Dermin, Dermira, DeuteRx, DiaMedica, Dianomi Therapeutics, Dicerna Pharmaceuticals, Dimerix Biosciences, Diurnal, DNA Biomedical Solutions, Dong-A ST, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dragonfly Therapeutics, DRI Capital, DRI Healthcare, Drugs for Neglected Diseases Initiative, DS Healthcare, DualityBio, Duke University, Durect, Dyadic International, Dyax, Dynavax Technologies, Eagle Pharmaceuticals, Eagle Pharmaceuticals (US), EA Pharma, Earendil Labs, Easton Pharmaceuticals, Eberhard Karls University Tubingen, Echo Therapeutics, Ecology Coatings, Eczacibasi Pharmaceuticals, Eddingpharm, Egalet, Eidos Therapeutics, Eiger BioPharmaceuticals, EirGen Pharma, Eirion Therapeutics, Eisai, Elanco, Elektrofi, Elencee, Elevar Therapeutics, Eli Lilly, Elite Pharmaceuticals, Elpiscience, Emerald Organic Growth, Emergent BioSolutions, Emmaus Life Sciences, Emory University, Emtora Biosciences, Enable Injections, Enalare Therapeutics, EndoCeutics, Endocyte, Endo International, EndoLogic, Endo Pharmaceuticals, Endo Ventures, EnGeneIC, Enochian Biosciences, Ensho Therapeutics, Ensoma, Entera Bio, Enteris Biopharma, Entest BioMedical, Entrada Therapeutics, Enumeral Biomedical, Enveric Biosciences, EnWave, Enzymotec, EPI Health, Epitopea, Epizyme, Epocal, EQRx, Equillium, Erasca, Ergomed, Esperion Therapeutics, Eterna Therapeutics, Eternity Healthcare, Ethypharm, Eton Pharmaceuticals, Euratom, Eureka Genomics, Eurofarma, EUSA Pharma, Evecxia, Evelo Biosciences, Everest Medicines, Everest Pharma, Eversana, Evoke Pharma, Evolva, Evotec, Evox Therapeutics, Ewopharma, Exacis Biotherapeutics, Exact Sciences, Exavir Therapeutics, Exelixis, Exeltis, Exicure, ExpreS2ion Biotechnologies, Exscientia, EyeCRO, Eyenovia, Eyevance, F-Star Therapeutics, F1 Oncology, Fairview Health System, Famy Life Sciences, FasTrack Pharmaceuticals, Fate Therapeutics, Fennec Pharmaceuticals, Ferozsons Laboratories, Ferrer, Ferring Pharmaceuticals, Fibrocell Science, Filament Health, First Wave Bio, Five Prime Therapeutics, Flexion Therapeutics, Foghorn Therapeutics, Forcefield Therapeutics, Forest Laboratories, FORMA Therapeutics, Formation Bio, ForSeeCon Eye Corporation, Fortify Therapeutics, Forty Seven, FORUS Therapeutics, Fosun Pharmaceutical, Fox Chase Chemical Diversity Center, Freeline Therapeutics, Freenome, Frequency Therapeutics, Fresenius Kabi Pharmaceuticals, Fresh Tracks Therapeutics, Frontier Biotech, FSD Pharma, FUJIFILM Cellular Dynamics, Fulcrum Therapeutics, Fusion Pharmaceuticals, FusionVax, FutureGen Biopharm, G1 Therapeutics, Gaelan Medical, Galapagos, Galderma, Galenica, Galmed Pharmaceuticals, Gamida Cell, GC Pharma, GE Healthcare, GEMMA Biotherapeutics, GenEdit, Genelux, Genentech, GeneQuantum Healthcare, GeneQuine Biotherapeutics, Generate Biomedicines, Generex Biotechnology, Generian Pharmaceuticals, Genevant Sciences, Genexine, Genfit, GenFleet Therapeutics, GenKOre, Genmab, Genor Biopharma, Genovis, Genrix Bio, GenScript ProBio, Gentium, Genzyme, German Cancer Research Center, Germfree, Geron, Gicell, Gilead Sciences, Gilgamesh Pharmaceuticals, Glaukos, Glenmark Generics Inc USA, Glenmark Pharmaceuticals, Glenmark Pharmaceuticals S.A., Global Blood Therapeutics, Goldfinch Bio, Gossamer Bio, GO Therapeutics, Government of Israel, GPCR Therapeutics, Gracell Biotechnologies, Grail, Gravitas Therapeutics, Graviton Bioscience, Gravocore, Grifols, Gritstone Bio, GSK, GT Biopharma, Guangzhou Xiangxue Pharmaceutical, Gurnet Point Capital, Hai Kang Life, Hail First Pharma, Hainan Sihuan Pharmaceutical, Haisco Pharmaceutical, Halo Labs, Halozyme Therapeutics, HanAll Pharmaceuticals, Handa Therapeutics, Handok Pharmaceuticals, Hangzhou Chance Pharmaceuticals, Hangzhou Highlightll Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, Hansen Medical, HanX Biopharmaceuticals, Harbour Biomed, Harmony Biosciences, Harvard University, HCW Biologics, Healios K.K., Health Canada, Healthcare Royalty Partners, Health Discovery, Heartseed, Heat Biologics, Hebrew University of Jerusalem, Hefei Life Science, Hefei Tianhui Incubation of Technologies, Heidelberg Pharma, HekaBio, Helmholtz Zentrum Munchen, Helsinn Therapeutics, HemoCleanse, Hemogenyx, Hemostemix, HemPup, Henlius Biotech, Hepalys Pharma, Hetero Labs, HIBio, HIBM Research Group, Hikma Pharmaceuticals, HilleVax, HLS Therapeutics, Hoffmann La Roche, Hollister Biosciences, Hookipa Pharma, Horizon Pharma Inc, Horizon Therapeutics, Hoth Therapeutics, Huadong Medicine, Humanigen, Huons, Hutchmed, Hyloris Pharmaceuticals, HyperGenomics, I-mab, IASO Biotherapeutics, Icahn School of Medicine at Mount Sinai, Ice + Jam, iCeutica, Ichnos Glenmark Innovation, Ichnos Sciences, IconOVir Bio, Iconovo, Icosavax, IDC-GP Pharm, IDEAYA Biosciences, Idera Pharmaceuticals, Idorsia, Idun Pharmaceuticals, IGM Biosciences, ImaginAb, Imbrium Therapeutics, iMetabolic Biopharma, Immatics Biotechnologies, Immedica, Immugenyx, ImmuneCyte Life Sciences, ImmuneOncia Therapeutics, ImmuneOnco Biopharmaceuticals, Immune System Regulation, ImmuNext, ImmunGene, Immunic, ImmunityBio, ImmunoGen, Immunome, Immunomedics, Immunomic Therapeutics, Immunovative Therapies, Immutep, ImmVira, Impax Laboratories, Imprimis Pharmaceuticals, Imugene, In4Derm, iNAP, Incannex Healthcare, Incuron, Incyte, InDex Pharmaceuticals, Indiana University, Indivior, Inexia, InfectoPharm, Infinity Pharmaceuticals, InflaRx, Inhibitor Therapeutics, Inhibrx, Initiator Pharma, Inmagene Biopharmaceuticals, InMed Pharmaceuticals, Innate Pharma, Innocoll, Innovate Biopharmaceuticals, Innovation Pharmaceuticals, Innovative Cellular Therapeutics, Innovent Biologics, Innovet, Innoviva, Innoviva Specialty Therapeutics, Innovus Pharmaceuticals, INO Therapeutics, Inovio, Inovio Pharmaceuticals, Insilico Medicine, Insitro, Insmed Inc, Inspiration Biopharmaceuticals, Inspirna, Instil Bio, Instrumentation Laboratory, Intact Therapeutics, Intarcia Therapeutics, Intas Pharmaceuticals, IntelGenx, Intellia Therapeutics, IntelliCell BioSciences, Intellikine, Internet Marketing Consortium, Intract Pharma, Intrexon, iNtRON Biotechnology, Intuitive Surgical, Invekra, InveniAI, Inventiva, Inverness Medical Innovations, Ion Channel Innovations, Ionis Pharmaceuticals, Iovance Biotherapeutics, IOVaxis Therapeutics, Ipsen, IRLAB, Iroko Pharmaceuticals, Ironwood Pharmaceuticals, Isofol Medical, Isomorphic Labs, Israeli National Authority for Technological Innovation, Itrom Pharmaceutical Group, Ivantis, Iveric Bio, iX Biopharma, Jacobio Pharmaceuticals, Jacobus Pharmaceutical, Jadeite Medicines, Jaguar Health, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Japan Tobacco, Jazz Pharmaceuticals, JCR Pharmaceuticals, JFC Technologies, Jiangsu Alphamab, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Jiangsu Lianhuan Pharmaceuticals, Jiangsu NHWA Pharmaceutical, Jinzhou Ahon Pharma, Ji Xing Pharmaceuticals, Johannes Gutenberg University, John Morley Foods, Joincare Pharmaceutical, Jolt Health, Jounce Therapeutics, Journey Medical, Joyo Pharmatech, JT Pharmaceuticals, Jubilant Life Sciences, Jumpcan Pharmaceutical, Juniper Pharmaceuticals, Juno Therapeutics, Junshi Biosciences, Jupiter Bioventures, Jupiter Wellness, Juventas Therapeutics, Juyou Biotechnology, JW Pharmaceutical, K2M, Kadmon Pharmaceuticals, Kainos Medicines, Kaken Pharmaceutical, Kalbe Genexine Biologics, KaloBios Pharmaceuticals, KalVista Pharmaceuticals, Karuna Therapeutics, Karveer Meditech, Karyopharm Therapeutics, Kashiv BioSciences, Kastle Therapeutics, Kazia Therapeutics, Kelonia Therapeutics, KemPharm, Kensey Nash, Keros Therapeutics, KeyBioScience, Keymed Biosciences, Kezar Life Sciences, Kiadis Pharma, Kieran Murphy, Kindred Bio, Kineta, Kinetic Concepts, Kiniksa Pharmaceuticals, Kintor, Kiq, Kiromic Biopharma, Kissei Pharmaceutical, Kite Pharma, Kitov Pharma, Klaria, Klinge Biopharma, Knighton Foods, Knight Therapeutics, Kodiak Sciences, Kolon Life Science, Korea Pharma, Kowa, Kowa Pharmaceuticals America, KPM Tech, Kraig Biocraft Laboratories, Kuhnil Pharmaceuticals, Kukbo, Kura Oncology, KVK-Tech, Kwang Dong Pharmaceutical, Kwangdong Pharmaceutical, Kymera Therapeutics, Kyn Therapeutics, Kyowa Hakko Kirin, Kyverna Therapeutics, L1 Systems, Laboratoires Thea, Laboratories Acbel, LadRx, La Jolla Pharmaceutical, Landos Biopharma, LaNova Medicines, Lantheus Holding, Lantheus Medical Imaging, Launch Therapeutics, Lava Therapeutics, Lee's Pharmaceutical, Lee Moffitt Cancer Center, Legend Biotech, LegoChem Biosciences, Leiden University, Leman SKL SA, LENZ Therapeutics, LEO Pharma, Lepu Biopharma, Les Laboratoires Servier, Level Brands, Lexicon Pharmaceuticals, LFB Biotechnologies, LG Life Sciences, LianBio, Lifestyle Delivery Systems, Ligand Pharmaceuticals, Lighthouse Pharmaceuticals, LimmaTech Biologics, Lindy Biosciences, Lineage Cell Therapeutics, Link Health, LIPAC Oncology, Lipidor, Lipocine, Lixte Biotechnology, Lobesity Pharma, LogicBio Therapeutics, Lorna Linda University, Lotus Pharmaceuticals, Loxo Oncology, Lubrizol, Lucideon, Lumenis, Lundbeck, Lung Therapeutics, Lycia Therapeutics, Lyell Immunopharma, Lynk Pharmaceuticals, Lyra Therapeutics, Lytix Biopharma, MaaT Pharma, MabCare Therapeutics, MabCure, Mabwell Bioscience, Macrogenics, Madrigal Pharmaceuticals, Magenta Therapeutics, MagnaPharm Trading, MainPointe, Mainz University Medical Centre, Mallinckrodt Pharmaceuticals, Mammoth Biosciences, Marathon Pharmaceuticals, Marina Biotech, Marinus Pharmaceuticals, Maruho, Marvanal, Marv Enterprises, Massachusetts General Hospital, Massachusetts Institute of Technology, Matrix Biomed, Mawson Infrastructure, Mayne Pharma, Mayo Clinic, MC2 Therapeutics, McComb Foundation, McEwen Centre for Regenerative Medicine, McQuade Center for Strategic Research and Development, MD Anderson Cancer Center, Meda, Medac, Medexus Pharmaceuticals, Mediar Therapeutics, Medica, Medica Avante, Medical Technologies Innovation Asia, Medice Arzneimittel Pütter, Medicines Patent Pool Foundation, Medicox, Medicure, MediGene, Medigus, MedImmune, MedinCell, Medison Pharma, Medivation, Medivir, MediWound, Medix, Medovex, MedRhythms, Medshine Discovery, Meiji Seika, MEI Pharma, MeiraGTx, Melinta Therapeutics, Melior Pharmaceuticals, Melmed, Memorial Sloan Kettering Cancer Center, Memory Dx, Menarini, Mercer University, Merck and Co, Merck KGaA, Merck Serono, Merck Sharpe & Dohme, Mereo BioPharma, Mersana Therapeutics, Merus, Mesoblast, Metacrine, Metavant, Methodist Hospital Houston, Microbio Shanghai, Micromet, Mikah Pharma, Millennium, MiMedx, Mimi’s Rock, MiNA Therapeutics, MindBio Therapeutics, Mindset Pharma, Minghui Pharmaceutical, Ministry of Health, Labor and Welfare, MiNK Therapeutics, Miraculins, Miralogx, Mira Pharmaceuticals, Mirati Therapeutics, Miravo Healthcare, Mirna Therapeutics, Miromatrix Medical, Mirum Pharmaceuticals, Mithra Pharmaceuticals, Mitobridge, Mitsubishi Tanabe Pharma, Moderna, Modis Therapeutics, Molecular Partners, Moleculin Biotech, Molipharma, Mologen, Molteni Farmaceutici, Momenta Pharmaceuticals, Monash University, Monopar Therapeutics, Monte Rosa Therapeutics, Morgan Stanley, Morningside Ventures, Morphic Therapeutic, MorphoSys, Mount Sinai Health System, MultiCell Immunotherapeutics, Multitude Therapeutics, Mundipharma, Munich Leukemia Laboratory, MycoMedica Life Sciences, Mylan Laboratories, Mylan Pharmaceuticals, MyoKardia, Myovant Sciences, Nabriva Therapeutics, Nanobiotix, NanoCarrier, NanoVibronix, NanoViricides, NantCell, NantKwest, Nantong Jinghua Pharmaceutical, NantWorks, Nanyang Technological University, Napo Pharmaceuticals, Natac Biotech, Natco Pharmaceuticals, National Cancer Institute, National Green Biomed, National Institute of Allergy and Infectious Diseases, National Resilience, National University Hospital, National University of Singapore, Navidea Biopharmaceuticals, Nektar Therapeutics, Neogenomics, Neoleukin Therapeutics, Neomorph, Neotope, Neovacs, Nephrogenex, Nephros, Nestle Health Science, Neuraxpharm, Neuren Pharmaceuticals, Neurimmune Therapeutics, Neurizon Therapeutics, Neuro Bio, NeuroBo Pharmaceuticals, Neurocrine Biosciences, NeuroRx, NeuroSense Therapeutics, NeuroSigma, NeuroTrauma, NeuroVive Pharmaceutical, NeuroVive Pharmaceutical Asia, Nevakar, NewAmsterdam Pharma, NewG Lab, NewLeaf Brands, Newron Pharmaceuticals, Newsoara Biopharma, New York University, NexMed, NextCure, Nextleaf Solutions, Nexvet, NGM Biopharmaceuticals, Nicox, Nicoya, Nimble Therapeutics, Nimbus Therapeutics, Nippon Shinyaku, NitricGen, Nkarta Therapeutics, NLC Pharma, NLS Pharmaceutics, Noile-Immune Biotech, Nona Biosciences, Nordic Bioscience, Norgine, North Star Holdings, NorthStar Medical Radioisotopes, Northwest Biotherapeutics, Northwestern University, Notable Labs, Notch Therapeutics, Novadaq Technologies, NovaDel Pharma, Novan, Novan Therapeutics, Novartis, Novartis Vaccines and Diagnostics, Novavax, NoveCite, Novellus Therapeutics, NovoCodex, Novocure, Novo Nordisk, Novus Biologicals, NRx Pharmaceuticals, NT Pharma, Nuance Pharma, Nucorion, Numab, Nunzi Pharmaceutical, Nurix Therapeutics, Nutech Medical, NutraOrigin, Nuvo Research, NXTGEN, Nykode Therapeutics, Nymox Pharmaceutical, Oberland Capital, ObsEva, Oceanus Bio, Ocugen, Ocular Therapeutics, Oculus Innovative Sciences, Ocumension Therapeutics, Ocuphire Pharma, Ohio State Innovation Foundation, OKYO Pharma, Olema Oncology, Omega Therapeutics, Omeros, OmniAb, Ona Therapeutics, OncoArendi Therapeutics, OncoCyte, Oncologie, Oncolytics Biotech, OncoMed Pharmaceuticals, Onconova Therapeutics, OncoSec Medical, OncoX BioPharma, Onegevity, Oneness Biotech, One Way Liver Genomics (OWL), ONK Therapeutics, Ono Pharmaceutical, Onxeo, Onyx Pharmaceuticals, Opexa Therapeutics, OPKO Health, Opsis Therapeutics, Opthea, OptiBiotix, Optieum Biotechnologies, OptiNose, Opus Genetics, Oragenics, Oramed Pharmaceuticals, Orchard Therapeutics, Orexia Therapeutics, Orexigen Therapeutics, Orexo, Organon, Organovo, Orgenesis, ORIC Pharmaceuticals, Orion, Orox Pharmaceuticals, OrthoCyte, OSE Immunotherapeutics, OSI Pharmaceuticals, Otsuka, Outpost Medicine, OvaMed, Ovid Therapeutics, Oxford BioMedica, Oxis Biotech, Oxygen Biotherapeutics, OxySure Systems, Oyster Point Pharma, Paion, Paladin Labs, Palatin Technologies, Palvella Therapeutics, Pan-Provincial Vaccine Enterprise, Pandion Therapeutics, PANTHERx Specialty Pharmacy, Paragon Biosciences, Paratek Pharmaceuticals, Parnell Pharmaceuticals, Par Pharmaceutical, Partner Therapeutics, Passage Bio, Patagonia Pharmaceuticals, PDL BioPharma, PDS Biotechnology, Pediatrix Therapeutics, PellePharm, Penwest Pharmaceuticals, Pepper Bio, PeptiDream, Perception Neuroscience, Pernix Therapeutics, Perugia University, Pfenex, Pfizer, Pharmacyclics, PharmaCyte Biotech, PharmaEssentia, PharmaMar, PharmaNova, Pharmanovia, Pharmastrip, PharmaTher, Pharming Group, PhaseBio Pharmaceuticals, Pheon Therapeutics, Philochem, Philogen, Phosphagenics, Photocure ASA, Phusion Laboratoies, Phyto Nutricare, Piedmont Pharmaceuticals, Pieris Pharmaceuticals, Pierre Fabre, Pint Pharma, Pipex Pharmaceuticals, Plandai Biotechnology, Plexium, Plexxikon, Pliant Therapeutics, Pluristem Therapeutics, POINT Biopharma, Polyphor, PolyPid, Polyrizon, Portola Pharmaceuticals, Poseida Therapeutics, Poxel, Pozen, Praxis Precision Medicines, Precigen, Precision BioSciences, PreMD, Premier Biomedical, Presage Biosciences, Pressure BioSciences, Prevail Therapeutics, Prilenia Therapeutics, PRIMA BioMed, Principia Biopharma, PRISM BioLab, Processa Pharmaceuticals, Professional Compounding Centers of America, ProGen Co, Progenics Pharmaceuticals, Proliant Health and Biologicals, Promedico, Prometheus Biosciences, Prometic Life Sciences, ProNAi Therapeutics, ProQR Therapeutics, Prosidion, Protagonist Therapeutics, Protalix BioTherapeutics, Proteonomix, Proteostasis Therapeutics, Proteovant Therapeutics, Prothena, ProtoKinetix, Provectus Biopharmaceuticals, Provention Bio, Providence Therapeutics, Psyence Therapeutics, PTC Therapeutics, PT Etana Biotechnologies, Pulmatrix, Puma Biotechnology, Purdue Pharma, PureTech Health, Purnovate, Pyramid Biosciences, Pyxis Oncology, QED Therapeutics, Qilu Pharmaceutical, QRxPharma, Qualigen, Queensland University of Technology, Quellis Biosciences, Quick Med Technologies, Quigley Corporation, Quince Therapeutics, Quoin Pharmaceuticals, Race Oncology, Radius Health, Rafael Pharmaceuticals, Rain Oncology, Rani Therapeutics, Ra Pharmaceuticals, Rayner Surgical, RayzeBio, Reata Pharmaceuticals, Recludix Pharma, Recordati, Recro Pharma, Recursion, RedHill Biopharma, Redx Pharma, Reedy Creek Investments, RegenaStem, Regeneron Pharmaceuticals, Regenity Biosciences, Regenxbio, Regnum, Regor Therapeutics, Relay Therapeutics, Relief Therapeutics, Relife, Relmada Therapeutics, RemeGen, RenalytixAI, ReNeuron, Renovacor, Repair Biotechnologies, Repare Therapeutics, Replicel Life Sciences, Repligen, Reprise Biomedical, Resarci Therapeutics, Res Nova Bio, Restoration Biologics, resTORbio, Resverlogix, Retrophin, Revance Therapeutics, ReveraGen BioPharma, reViral, Revitope Oncology, Revive Therapeutics, rEVO Biologics, Revolution Medicines, Rexahn Pharmaceuticals, Rezolute, Rgene, Rhinomed, Rhizen Pharmaceuticals, Rhythm Pharmaceuticals, Ribon Therapeutics, Rigel Pharmaceuticals, Ripple Therapeutics, RNL Bio, Roche, Rockefeller University, Rocket Pharmaceuticals, RogCon Biosciences, Roivant Sciences, Rosetta Genomics, Roswell Park Cancer Institute, ROTOP Pharmaka, Royalty Pharma, RQ Biotechnology, RST Biomedikal Sanayi, Rubius Therapeutics, Ruthigen, RXi Pharmaceuticals, Ryvu Therapeutics, S2 Therapeutics, SACCO, Sagard Healthcare Royalty Partners, Sage Therapeutics, Salix Pharmaceuticals, Salk Institute, Sam Amer, SAMIL Pharm, Sanara MedTech, SanBio, Sandoz, Sangamo Therapeutics, Saniona, Sanofi, Sanofi-Aventis, Sanofi-Pasteur, Sanpellegrino Cosmetics, SanReno Therapeutics, Santarus, Santen Pharmaceutical, Santhera Pharmaceuticals, Sanuwave Health, SA Pathology, Sapientia Pharmaceuticals, Sarepta Therapeutics, Sato Pharmaceutical, Satsuma Pharmaceuticals, Sayre Therapeutics, Scancell, Scholar Rock, Schrodinger, SciBase, SciClone Pharmaceuticals, Scintomics, SciSparc, Scopus BioPharma, Scorpion Therapeutics, Scribe Therapeutics, Scripps Research Institute, Scynexis, Seagen, Searchlight Pharma, Seattle Genetics, Second Genome, Secura Bio, Seelos Therapeutics, Seer, Sekris Biomedical, Selecta Biosciences, SELLAS Life Sciences Group, SemaThera, Senetek, Senior Paradise, Senju Pharmaceutical, Sensory Cloud, Sentynl Therapeutics, Seqirus, Seres Therapeutics, Serina Therapeutics, Sermonix Pharmaceutical, Serum Institute of India, Sesen Bio, SevenScore Pharmaceuticals, Shandong Luoxin Pharma, Shanghai Haohai Biological Technology, Shanghai Pharmaceuticals Holdings, Shattuck Labs, Sheba Medical Center, Shenzhen BioScien Pharmaceuticals, Shenzhen Salubris Pharmaceuticals, Shield Therapeutics, Shin Nippon Biomedical Laboratories, Shionogi, Shire Pharmaceuticals, Shore Therapeutics, Siemens Healthcare Diagnostics, Sierra Oncology, Sigilon Therapeutics, Sigma-Tau, Silence Therapeutics, Silo Pharma, Simcere Pharmaceuticals, Simcere Zaiming, Sinclair Pharmaceuticals, Singlomics Biopharmaceuticals, Sinobiopharma, Sino Biopharmaceutical, SinoMab Bioscience, Sinopharm, Sinovant Sciences, Sio Gene Therapies, Sirion Biotech, Sirius Therapeutics, Sirtex Medical, Sitryx, SK Biopharmaceuticals, Skinvera, SkyePharma, Skyline Diagnostics, SmartCella, Smith & Nephew, Sol-Gel, Solarvest BioEnergy, Solasia Pharma, Soliance, Solid Biosciences, Soligenix, Sona Nanotech, Sonnet BioTherapeutics, Sonoma BioTherapeutics, Sorrento Therapeutics, Sosei, Sosei Heptares, SOTIO, Spark Therapeutics, Specialised Therapeutics, Spectranetics, Spectrum Pharmaceuticals, Spencer Pharmaceutical, Spero Therapeutics, Spinal USA, Spring Bank Pharmaceuticals, SpringWorks Therapeutics, Sprint Biosciences, Spruce Biosciences, St. Jude Children's Research Hospital, STADA Arzneimittel, Staidson (Beijing) BioPharmaceuticals, Stanford University, Starton Therapeutics, Stealth BioTherapeutics, Stellar Biotechnologies, Stemline Therapeutics, StemSynergy, St Jude Medical, Stoke Therapeutics, Strongbridge Biopharma, Sucampo AG, SUDA Pharmaceuticals, Sumitomo Dainippon Pharma, Sumitomo Pharmaceuticals, Summit Therapeutics, Sunesis Pharmaceuticals, Sunovion Pharmaceuticals, Sun Pharmaceutical, Sunshine Lake Pharma, SuperNova Diagnostics, Surface Oncology, Surrozen, Sutro Biopharma, Suzhou Connect Biopharmaceuticals, Suzhou Sinovent Pharmaceuticals, Swedish Orphan Biovitrum, Sydys Corporation, SymBio Pharmaceuticals, Symbollon, Synaffix, Syndax Pharmaceuticals, Synergy Strips, Synthon, Syntopix, Syros Pharmaceuticals, Systec, T-Cell Protect Hellas, Tactical Relief, Taiba, TaiGen Biotechnology, Taiho, Takeda Pharmaceutical, Takeda Pharmaceuticals U.S.A, Talaris Therapeutics, Talem Therapeutics, Tango Therapeutics, Target Group, Targovax, Tarsus Pharmaceuticals, Tarveda Therapeutics, Tasly Pharmaceuticals, Tauriga Sciences, Tavros Therapeutics, Taysha Gene Therapies, TB Alliance, TearLab, Technion Research and Development Foundation, Teijin, Tela Bio, Telcon RF Pharmaceuticals, Telix Pharmaceuticals, Telomir Pharmaceuticals, Temple University, Tenacia Biotechnology, TeneoBio, Terns Pharmaceuticals, TerSera Therapeutics, Terumo, Tesaro, Tetra Bio-Pharma, TetraLogic Pharmaceuticals, Tetraphase Pharmaceuticals, Teva Pharmaceutical Industries, Texas A&M University, Texas Heart Institute, TFF Pharmaceuticals, TG Therapeutics, Tharimmune, The Medicines Company, Therakine, Theramex, Theranexus, TherapeuticsMD, Therapeutic Solutions International, Therapharm, Therapyx, Theratechnologies, Theravance, Theravance Biopharma, The Regents of the University of California, Theseus Pharmaceuticals, Thorne Research, Threshold Pharmaceuticals, TiGenix, Tilray, Titan Pharmaceuticals, Titterington Veterinary Services, TiumBio, Tiziana Life Sciences, Tizona Therapeutics, TLC BioSciences, Tocagen, Todos Medical, Tonghua Dongbao Pharma, TONIX Pharmaceuticals, Torch Biosciences, Torii Pharmaceutical, TRACON Pharmaceuticals, Tramorgan, Transcenta, Transgene, Translate Bio, Travere Therapeutics, TreeFrog Therapeutics, Trek Therapeutics, Trellis Bioscience, Trevena, Trimedyne, Trimeris, TriSalus Life Sciences, TrovaGene, TScan Therapeutics, TTFactor, Tubulis, Tufts Medical Center, Tufts University, Turing Pharmaceuticals, Turning Point Therapeutics, Turnstone Biologics, Twist Bioscience, Tyme Technologies, Ubix Therapeutics, Ultragenyx Pharmaceuticals, Uluru, Undisclosed Company, Unigene Laboratories, Union Springs Pharmaceuticals, UNION Therapeutics, UniQure, United Therapeutics, Universal Cells, University College Dublin, University Health Network, University of Alberta, University of Arizona, University of Basel, University of California, University of California San Francisco, University of Central Florida Research Foundation, University of Chicago, University of Colorado, University of Connecticut, University of Florida Research Foundation, University of Geneva, University of Heidelberg, University of Louisville, University of Massachusetts Medical School, University of Miami, University of Missouri, University of North Carolina, University of Notre of Dame, University of Pennsylvania, University of Southampton, University of Texas, University of Tubingen, University of Virginia, University of Washington, University of Western Sydney, University of Zurich, UOP, Uppsalagruppen Medical, Upstream Peripheral Technologies, UroGen Pharma, Urovant Sciences, Vaccibody, Vaccinex, Vactech, Valeant Pharmaceuticals, ValiPharma, Valneva, Valor Biotherapeutics, Vanda Pharmaceuticals, Vanderbilt University, Vasomune Therapeutics, Vaxart, Vaxent, VaxEquity, VAYA Pharma, VBI Vaccines, VBL Therapeutics, Vectura, Veloxis Pharmaceuticals, Veracyte, Verastem, Vera Therapeutics, Veraxa Biotech, Verenium, Vericel, VerImmune, Verity Pharmaceuticals, VeroScience, Verrica Pharmaceuticals, Vertex Pharmaceuticals, Verve Therapeutics, Viatris, VIB, Vida Concepts, Vifor-Fresenius Medical Care Renal Pharma, Vifor Pharma, ViiV Healthcare, Vincera Pharma, Virbac, Vir Biotechnology, Viridian Therapeutics, Viropharma, VistaGen Therapeutics, Vivelix Pharmaceuticals, Vividion Therapeutics, Vivus, VolitionRX, Voronoi, Voyager Therapeutics, vTv Therapeutics, Vyera Pharmaceuticals, Vyluma, VYNE Therapeutics, Vyrix Pharmaceuticals, Warp Drive Bio, Watson Pharmaceuticals, WAVE Life Sciences, Wellcome Trust, Werewolf Therapeutics, Whitehead Institute, Wigen Biomedicine, Wilex, Windtree Therapeutics, Winhealth Pharma Group, Wisconsin Alumni Research Foundation, World Class Extractions, WPD Pharmaceuticals, WUGEN, WuXi Biologics, WY Biotech, X4 Pharmaceuticals, Xbiome, Xbrane Biopharma, Xencor, Xenetic Biosciences, Xenon Pharmaceuticals, XERIS Pharmaceuticals, Xilio Therapeutics, Xlife Sciences, Xoma, XPhyto Therapeutics, Xspray Pharma, XTL Biopharmaceuticals, Xuanzhu Biopharma, XyloCor Therapeutics, Xynomic Pharmaceuticals, Xyphos Biosciences, Y-Biologics, Y-mAbs Therapeutics, Yakult Honsha, Yale University, Yeda Research and Development Company, Yeugnam University, Yissum Research Development, Yuhan Corporation, Yungjin Pharmaceutical, ZAI Laboratory, Zalicus, Zealand Pharma, Zenas BioPharma, Zenitech, Zenith Epigenetics, Zentalis Pharmaceuticals, Zenyaku Kogyo, Ziopharm Oncology, Zogenix, ZS Pharma, Zydus Cadila, Zylo Therapeutics, Zymeworks

Comprehensive and Reliable Analysis of Life Sciences Partnering Deals

The Current Partnering reports are built on a foundation of rigorous data collection, in-depth analysis, and continuous updates. Designed to serve as a trusted resource for life sciences professionals, the reports deliver detailed insights into trends, terms, and financial structures of global partnering agreements.

---

1. Rigorous and Timely Updates

To ensure users have the most current and relevant information, Current Partnering reports are updated every six months. This systematic update cycle guarantees that readers have access to the latest deal announcements, industry trends, and financial insights. As the life sciences sector evolves, the reports adapt to reflect emerging patterns and opportunities in deal-making.

---

2. Expert Review and Insightful Analysis

Our team of expert analysts conducts a meticulous review of deal data, uncovering key trends, negotiating patterns, and notable agreements. Reports provide not just raw data but actionable intelligence to guide decision-making.

Key deliverables include:

• Overview of recent trends in deal-making
• Examples of high-profile and representative deals
• Analysis of royalty rates, payment triggers, and financial structures

The analysis is designed to empower readers with the information needed to benchmark agreements, understand negotiation dynamics, and prepare for future partnerships.

---

3. Trusted Data Sources

The reports leverage the proprietary Current Agreements database, which is updated daily to reflect new deal announcements and financial disclosures. Data is sourced from publicly available, verifiable resources to ensure accuracy and transparency, including:

• Official press releases from companies involved in the deals
• Investor and company presentations
• Regulatory filings, including SEC submissions and other official disclosures
• Publicly accessible company websites and conference materials

Every data point is carefully referenced, enabling users to verify the information independently for added confidence.

---

4. Comprehensive Coverage of Partnering and Deal Types

The reports provide in-depth coverage of a wide range of partnering structures, capturing the diversity of the life sciences deal landscape. This includes:

• Licensing and sub-licensing agreements
• Co-development, co-promotion, and collaborative R&D deals
• Asset purchases and assignments
• Distribution, marketing, and manufacturing agreements
• Equity purchases, loans, and royalty financing
• Joint ventures, grants, and option agreements

Each deal type is analyzed to uncover trends and financial benchmarks specific to that category, helping readers understand its role and impact in the broader life sciences ecosystem.

---

5. Detailed Categorization of Deal Records

To make the data accessible and actionable, every deal record in the report is meticulously categorized by:

• Industry Sector: Pharmaceutical, biotechnology, diagnostics, and more
• Therapeutic Area: Focus on specific diseases or medical conditions
• Technology Type: Biologics, small molecules, gene therapies, and other platforms
• Deal Components: Licensing, co-promotion, collaborative R&D, asset purchase and many more
• Financial Terms: Dollar values associated with agreements for clear benchmarking including headline, upfront, milestones and royalties
• Stage of Development: Preclinical, clinical, or commercial stage agreements
• Geographic Focus: Territories covered and excluded under the agreement
• Supporting Documents: Press releases, SEC filings, and, where available, full contract documents

This categorization ensures that users can quickly identify the deals most relevant to their interests and conduct detailed comparisons.

---

6. Standardized Financial Comparisons

To facilitate cross-border comparisons, all financial figures are converted into US dollars using the exchange rate applicable on the deal announcement date. This standardization enables users to easily evaluate and benchmark deals from different regions without currency fluctuations affecting the analysis.

---

7. Access to Contractual Details

A unique feature of the Current Partnering reports is the inclusion of contractual details where available. Contract documents, sourced from public filings such as SEC submissions, provide insights into:

• Precise royalty rates and payment structures
• Exclusivity terms and rights granted to partners
• Development, supply, and commercialization responsibilities
• Audit procedures, confidentiality clauses, and dispute resolution mechanisms
• Conditions for termination, change of ownership, sublicensing, and subcontracting
• Jurisdiction and governing law for agreements

This granular detail empowers users to understand not only the financial terms of agreements but also the strategic frameworks underpinning successful partnerships.

---

8. Transparency and Verifiability

All data and information presented in the reports are backed by clearly identified sources. This transparency allows users to:

• Verify the authenticity of deal data
• Reference the original press releases, filings, or announcements
• Build confidence in the reliability of the information provided

---

9. Designed for Decision-Making

The Current Partnering reports are purpose-built for business development professionals, licensing managers, legal advisors, and industry analysts. Whether you are preparing for negotiations, benchmarking deals, or conducting due diligence, the reports deliver the insights you need to make informed, strategic decisions.

---

Why Trust Current Partnering Reports?

• Proven Expertise: Developed by a team of experienced analysts with deep knowledge of the life sciences sector
• Data Integrity: Sourced exclusively from publicly available, verifiable resources
• Practical Insights: Focused on actionable intelligence rather than raw data
• Global Perspective: Covers deals from all major markets, ensuring comprehensive industry coverage
• User-Centric Design: Organized for ease of use, with hyperlinked deal records and accessible contract details

---

By leveraging this methodology, Current Partnering reports provide unmatched clarity, depth, and reliability, empowering professionals to navigate the complex world of life sciences partnerships with confidence.